Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases
Graphical abstract
Section snippets
Acknowledgements
We thank Dr. A. Mirza, M. Richards and Dr. M. Liu for assistance in the spectroscopic characterisation of test compounds and Dr M. Lamers for the preparation of CHK1 protein. This work was supported by Cancer Research UK [CUK] Grant Numbers C309/A2187, C309/A8274 and C309/A8365 and by The Institute of Cancer Research. We acknowledge NHS funding to the NIHR Biomedical Research Centre.
References and notes (24)
- et al.
Bioorg. Med. Chem.
(2006) - et al.
Drug Discovery Today
(2004) - et al.
Chem. Biol.
(2005) Nat. Rev. Drug Disc.
(2002)- et al.
J. Med. Chem.
(2009) - et al.
Mol. Cancer Ther.
(2008) - et al.
Clin. Cancer Res.
(2008) - et al.
Br. J. Cancer
(2008) - et al.
Curr. Opin. Drug Discov. Devel.
(2007) - et al.
J. Med. Chem.
(2009)
Cited by (27)
2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion
2014, Bioorganic and Medicinal ChemistryCitation Excerpt :Swern oxidation22 to the ketones 19a–e was followed by acid-induced cyclisation to form the 3-aryl-8-chloroimidazo[1,2-a]pyrazines 20a–e. 3-substituted imidazo[1,2-a]pyrazine derivatives have previously been reported as kinase inhibitors,23–25 and a range of strategies is available for synthesis of the key heterocyclic core. However, 2-aryl imidazo[1,2-a]pyrazine derivatives have been less frequently explored,26 and consequently fewer synthetic approaches to these compounds have been reported.
Synthesis and evaluation of heteroaryl substituted diazaspirocycles as scaffolds to probe the ATP-binding site of protein kinases
2013, Bioorganic and Medicinal ChemistryCitation Excerpt :The use of PKA as a surrogate of other AGC family kinases is well established.24,45 The binding mode for 12 (PDB 3Z01; Fig. 3A) showed the purine hydrogen bonding to the hinge peptide as expected, and the nitrogen of the azaspirocycle interacting with the side chain carboxylate of Glu127, a residue located in the ribose pocket and postulated to be involved in communicating ATP-binding to substrate–peptide binding residues.46 Compounds 14 and 16 (PDB 3Z02, 3ZO3; Fig. 3B, C) bound similarly to the hinge region but displayed an alternative interaction in the ribose pocket, with the azaspirocycle nitrogen interacting with the side chain carboxylate of Asp184 from the DFG motif, and close to Asn171 and the backbone carbonyl of Glu170.
Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates
2012, Bioorganic and Medicinal Chemistry LettersSix-membered ring systems. diazines and benzo derivatives
2011, Progress in Heterocyclic ChemistryCitation Excerpt :Many derivatives were synthesized and evaluated as potential cancer treatments. Compounds were found to be potent inhibitors of P38α MAP kinase (124) 〈10JMC1128〉, the Wnt2/β-catenin pathway in non-small-cell lung cancer cell lines 〈10BMCL5900〉, the folate cycle 〈10BMC7773〉, Pim kinase 〈10EJM5520〉, Aurora kinase (126) 〈10BMCL6739, 10BMCL5170, 10BMCL5988〉, CHK1 〈10BMCL4045〉, and Nek2 (127) 〈10JMC7682〉. The diaminopteridine-benzenesulfonamide 128 was evaluated as an inhibitor of carbonic anhydrases and dihydrofolate reductase 〈10BMC5081〉, while the phenazine 130 was evaluated as an inhibitor of quinone reductases 1 and 2, and inducible nitric oxide synthase 〈10JMC8688〉.
Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells
2010, Bioorganic and Medicinal Chemistry LettersHigh-throughput virtual screening of novel CHK1 inhibitors
2023, Onkologia i Radioterapia